AU7709300A - Drug discovery using gene expression profiling - Google Patents
Drug discovery using gene expression profilingInfo
- Publication number
- AU7709300A AU7709300A AU77093/00A AU7709300A AU7709300A AU 7709300 A AU7709300 A AU 7709300A AU 77093/00 A AU77093/00 A AU 77093/00A AU 7709300 A AU7709300 A AU 7709300A AU 7709300 A AU7709300 A AU 7709300A
- Authority
- AU
- Australia
- Prior art keywords
- gene expression
- drug discovery
- expression profiling
- profiling
- discovery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/20—Heterogeneous data integration
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Databases & Information Systems (AREA)
- Bioethics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15610599P | 1999-09-24 | 1999-09-24 | |
US60156105 | 1999-09-24 | ||
PCT/US2000/026050 WO2001020998A1 (en) | 1999-09-24 | 2000-09-22 | Drug discovery using gene expression profiling |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7709300A true AU7709300A (en) | 2001-04-24 |
Family
ID=22558115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU77093/00A Abandoned AU7709300A (en) | 1999-09-24 | 2000-09-22 | Drug discovery using gene expression profiling |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7709300A (en) |
WO (1) | WO2001020998A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8501911B2 (en) | 1999-02-24 | 2013-08-06 | Biomarck Pharmaceuticals, Ltd | Methods of reducing inflammation and mucus hypersecretion |
US7544772B2 (en) | 2001-06-26 | 2009-06-09 | Biomarck Pharmaceuticals, Ltd. | Methods for regulating inflammatory mediators and peptides useful therein |
US6960439B2 (en) | 1999-06-28 | 2005-11-01 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
US6964850B2 (en) | 2001-11-09 | 2005-11-15 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
WO2004007681A2 (en) * | 2002-07-12 | 2004-01-22 | Duke University | Genetic susceptibility genes for asthma and atopy and asthma-related and atopic-related phenotypes |
US7807465B2 (en) | 2004-10-27 | 2010-10-05 | Duke University | Methods for identifying an individual at increased risk of developing coronary artery disease |
US7790390B2 (en) | 2004-10-27 | 2010-09-07 | Duke University | Methods for identifying an individual at increased risk of developing coronary artery disease |
NZ577196A (en) | 2005-01-20 | 2011-06-30 | Biomarck Pharmaceuticals Ltd | Mucin hypersecretion inhibitors based on the structure of MANS and methods of use |
CN103990111B (en) | 2006-07-26 | 2016-08-31 | 拜欧马克医药有限公司 | Reduce the method for inflammatory mediator release and can be used for the peptide of the method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6114114A (en) * | 1992-07-17 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
AU8382998A (en) * | 1997-07-02 | 1999-01-25 | Genzyme Corporation | P53 influenced gene expression |
AU9200298A (en) * | 1997-08-22 | 1999-03-16 | Yale University | A process to study changes in gene expression in stem cells |
AU9200398A (en) * | 1997-08-22 | 1999-03-16 | Yale University | A process to study changes in gene expression in granulocytic cells |
AU759785C (en) * | 1998-05-05 | 2003-12-04 | Gene Logic, Inc. | A process to study changes in gene expression in T lymphocytes |
JP2002530092A (en) * | 1998-11-13 | 2002-09-17 | キュラゲン コーポレイション | Compositions and methods related to the peroxisome proliferator-activated receptor-α-mediated pathway |
-
2000
- 2000-09-22 AU AU77093/00A patent/AU7709300A/en not_active Abandoned
- 2000-09-22 WO PCT/US2000/026050 patent/WO2001020998A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001020998A1 (en) | 2001-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1071301A (en) | Pharmaceutical compounds | |
AU5259100A (en) | Medicament | |
AU3569800A (en) | Pyrimidine compounds with pharmaceutical activity | |
AU2002259196A1 (en) | Gene expression profiling | |
AU1469001A (en) | Capacitive mouse | |
AU6281100A (en) | Novel diketopiperazines | |
AU7815000A (en) | Targeted drug activation | |
AU5073400A (en) | Sulfonamide compounds with pharmaceutical activity | |
AUPP938799A0 (en) | Electrodes | |
AU1132601A (en) | Feature interactions | |
AU6715600A (en) | Pharmaceutical formulations | |
AUPQ262599A0 (en) | Gene expression | |
AU1586500A (en) | Computer arrangement using non-refreshed dram | |
AU7709300A (en) | Drug discovery using gene expression profiling | |
AU1645700A (en) | Oenothein medicaments | |
AU4977300A (en) | Pharmaceutical formulations | |
AU5722900A (en) | Pharmaceutical compounds | |
AU6036100A (en) | New pharmaceutically active compounds | |
AU1385801A (en) | Pharmaceutical formulations | |
AU7606100A (en) | Gene expression profiles | |
AU2376200A (en) | Insulin-synthesis genes | |
AU7318700A (en) | Novel transaldolase gene | |
AU2732000A (en) | Reverse gene therapy | |
AU2001247444A1 (en) | Erbeta-mediated gene expression | |
AUPQ749100A0 (en) | New epilespy gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |